Clones with different metastatic capacity and variant selection during metastasis: a problematic relationship

Area of Science:

• Oncology
• Cancer Metastasis Research
• Tumor Biology

Background:

• TS/A is a metastasizing mammary adenocarcinoma cell line derived from spontaneous BALB/c mouse tumors.
• Understanding the mechanisms of cancer metastasis is crucial for developing effective treatments.

Purpose of the Study:

• To investigate whether serial in vivo selection enhances the metastatic capacity of TS/A cells.
• To compare the efficacy of intravenous (IV) versus subcutaneous (SC) selection routes for enriching highly metastatic cell populations.
• To evaluate the in vitro growth properties of selected variants.

Main Methods:

• TS/A cells were injected SC or IV into syngeneic mice.
• Resulting lung metastases/colonies were cultured and reinjected over 10 cycles.
• Variants were compared to parental cells and in vitro-selected high metastatic clones.
• In vitro growth characteristics were assessed.

Main Results:

• Serial in vivo selection (IV or SC) did not yield variants with higher metastatic capacity than the parental TS/A line.
• In vitro-selected high metastatic clones produced significantly more metastases than in vivo-selected variants.
• Intravenously selected (COL) variants showed significantly higher lung colonization than subcutaneously selected (META) variants, parental cells, or in vitro clones.
• COL and META variants lacked the in vitro growth properties of in vitro-selected high metastatic clones.

Conclusions:

• Serial in vivo selection, including IV and SC routes, failed to enrich for highly metastatic TS/A populations.
• Intravenous selection specifically enriched for variants with high lung-colonizing ability, but not necessarily overall metastatic potential.
• In vitro selection methods appear more effective for isolating high metastatic TS/A clones compared to serial in vivo passage.